Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | SCN4A | P35499 | 7/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | SCN1A | P35498 | 2/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.41 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.41 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL358326 | 0.85 | ALDH1A1 (0.52) | CD44CYP3A4TDP1TSHRPIK3CA | |
| Hydrochloric Acid SCHEMBL4332744 | 0.82 | ALDH1A1 (0.50) | CD44CYP3A4TDP1TSHRPIK3CA | |
| SCHEMBL145464 | 0.82 | ALDH1A1 (0.48) | CYP3A4TSHRALDH1A1SCN4ALMNA | |
| SCHEMBL1341407 | 0.81 | ALDH1A1 (0.47) | CD44CYP3A4TDP1TSHRALDH1A1 | |
| SCHEMBL17368402 | 0.80 | ALDH1A1 (0.40) | CD44CYP3A4TDP1TSHRPIK3CA | |
| SCHEMBL31607690 | 0.78 | ALDH1A1 (0.46) | CD44CYP3A4TDP1TSHRPIK3CA | |
| SCHEMBL2203933 | 0.78 | ALDH1A1 (0.46) | CD44CYP3A4TDP1TSHRPIK3CA | |
| SCHEMBL210128 | 0.76 | ALDH1A1 (0.62) | CYP3A4TDP1TSHRALDH1A1ADRA2B | |
| SCHEMBL23146537 | 0.76 | ALDH1A1 (0.50) | CD44CYP3A4TDP1TSHRPIK3CA | |
| SCHEMBL3787782 | 0.76 | ENPP2 (0.47) | CYP3A4TDP1TSHRPIK3CAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9249091-B2 | Post-treated sulfurized salt of an alkyl-substituted hydroxyaromatic composition | CHEVRON ORONITE COMPANY LLC (US) | 2016-02-02 | — | — | US | claimed |
| US-20130165359-A1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | CHEVRON ORONITE COMPANY LLC (US) | 2013-06-27 | — | — | US | claimed |
| US-7056986-B2 | ethylene monomer can be a vinyl ketone, ether, ester, halide, nitrile, aromatic, or an allyl ether; acrylic monomer can be a mono- or diacid or monoester of a diacid; a monoamine, a guanidine compound, and an aromatic diamine; improved vulcanizability, balance between processability and compression set | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2006-06-06 | — | — | US | claimed |
| CN-86108684-A | The preparation method of three grades of 2-chloro-monoacetylaniline missible oil | — | 1987-07-29 | — | — | CN | claimed |
| US-12433826-B2 | Primer and kit of primer and dental material | KETTENBACH GMBH & CO. KG (DE) | 2025-10-07 | — | — | US | disclosed |
| WO-2024120471-A1 | COMPOUNDS TARGETING MUTANT OF P53 | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024074611-A1 | PRMT5 INHIBITORS | Ryvu Therapeutics S.A. (PL) | 2024-04-11 | — | — | WO | disclosed |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ANTARES THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ANTARES THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ANTARES THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |
| CN-116997549-A | Pyrrolo [3,2-C ] pyridin-4-one derivatives for the treatment of cancer | 蝎子疗法股份有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-114874189-B | Substituted heteroaryl derivatives, compositions and uses thereof | 深圳市塔吉瑞生物医药有限公司 | 2023-09-29 | — | — | CN | disclosed |
| US-20040266922-A1 | Ethylene-acrylic copolymer rubber composition | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2004-12-30 | — | — | US | disclosed |
| EP-1449881-A1 | ACRYLIC RUBBER COMPOSITION | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2004-08-25 | — | — | EP | disclosed |
| EP-1440966-A1 | Indole derivatives useful for the treatment of diseases | Pfizer Limited (GB) | 2004-07-28 | — | — | EP | disclosed |
| US-20040116503-A1 | Indole derivatives useful for the treatment of diseases | PFIZER INC. | 2004-06-17 | — | — | US | disclosed |
| WO-2004032921-A1 | INDOLE DERIVATIVES AS BETA-2 AGONISTS | PFIZER LIMITED (GB) | 2004-04-22 | — | — | WO | disclosed |
| EP-0468647-A1 | Anionic compounds | ZENECA LIMITED (GB) | 1992-01-29 | — | — | EP | disclosed |
| CN-86108684-A | The preparation method of three grades of 2-chloro-monoacetylaniline missible oil | — | 1987-07-29 | — | — | CN | disclosed |
| US-4517005-A | Aminophenol urease inhibitors and urease inhibited urea based fertilizer compositions | ALLIED CORPORATION (US) | 1985-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433826-B2 | Primer and kit of primer and dental material | MVD, KIT, POLL | CD44 246/4885CYP3A4 2636/4885TDP1 1732/4885 |
| US-20130165359-A1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | TST, PAH, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | CD44 438/4885CYP3A4 2118/4885TDP1 1379/4885 |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ERBB2, EGFR, ERBB3 | CD44 3124/4885CYP3A4 2982/4885TDP1 1198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.